Report Categories

The global Hirudin market size is expected to reach $ 5018.9 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Hirudin market size was valued at USD 4090.1 million in 2023 and is forecast to a readjusted size of USD 5018.9 million by 2030 with a CAGR of 3.0% during review period.

USD3480.00

Add To Cart

The global Recombinant Hirudin market size is expected to reach $ 2357.5 million by 2030, rising at a market growth of 5.3% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Recombinant Hirudin market size was valued at USD 1646.3 million in 2023 and is forecast to a readjusted size of USD 2357.5 million by 2030 with a CAGR of 5.3% during review period.

USD3480.00

Add To Cart

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

USD3480.00

Add To Cart

The global Recombinant Hirudin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

According to our (Global Info Research) latest study, the global Recombinant Hirudin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

USD3480.00

Add To Cart

The Hirudin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

The Hirudin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart